Svĕrák J, Hejcmanová D, Peregrin J, Erben J
Cas Lek Cesk. 1989 Feb 10;128(7):206-8.
Over the past 11 years, neuroretinopathy was seen in 26 hemodialyzed patients, in an average 5.3% of the patients receiving treatment. During the past 4 years, the rate of incidence had dropped to 1.6%. Neuroretinopathy is most likely to develop in the first two years of artificial kidney treatment. The mean survival time following an attack of neuroretinopathy in 16 decreased patients was 19.4 months. Three patients underwent successful kidney transplantation, 50% were normotensives. As part of the subsequent search for other pathogenetic factors, a high incidence of pathological values of nitrogenous substances was found (urea in 77%, creatinine in 76%, uric acid in 42%). 85% suffered from electric retinal function impairment.
在过去11年中，26例接受血液透析的患者出现了神经视网膜病变，占平均接受治疗患者的5.3%。在过去4年中，发病率已降至1.6%。神经视网膜病变最有可能在人工肾治疗的头两年发生。16例病情加重患者在出现神经视网膜病变后的平均存活时间为19.4个月。3例患者成功进行了肾移植，其中50%血压正常。在随后寻找其他致病因素的过程中，发现含氮物质的病理值发生率很高（尿素为77%，肌酐为76%，尿酸为42%）。85%的患者存在视网膜电功能损害。
